Results 31 to 40 of about 433,914 (257)

Improvise the working condition at Kilang Beras Jelapang Selatan (M) Sdn. Bhd. [PDF]

, 2020
Kilang Beras Jelapang Selatan (M) Sdn. Bhd. or known as KBJS was established on 11th March 1988. KBJS is located at industrial area, Batu 2 ¾ Jalan Salleh,8400, Muar, Johor. The size of the factory is more than 2.5 acre.
Mahmood, Salwa, Ngadiman, Nor Hasrul Akhmal, Tajurahim, Nurul Ainina Nadhirah   +2 more
core   +1 more source

Mesenchymal stem cells in the treatment of ischemic stroke [PDF]

Клиническая практика
Over the past two decades, multiple preclinical studies have shown that transplantation of mesenchymal stem cells leads to a pronounced positive effect in animals with experimental stroke.
Daria D. Namestnikova, Daria B. Kovalenko, Irina A. Pokusaeva, Daria A. Chudakova, Ilya L. Gubskiy, Konstantin N. Yarygin, Vladimir P. Baklaushev   +6 more
doaj   +1 more source

Potential use of human periapical cyst-mesenchymal stem cells (hPCy-MSCs) as a novel stem cell source for regenerative medicine applications [PDF]

, 2017
Mesenchymal stem cells (MSCs) are attracting growing interest by the scientific community due to their huge regenerative potential. Thus, the plasticity of MSCs strongly suggests the utilization of these cells for regenerative medicine applications.
Codispoti, Bruna, Marrelli, Massimo, Pacifici, Andrea, Pacifici, Luciano, Paduano, Francesco, Palmieri, Francesca, Tatullo, Marco   +6 more
core   +2 more sources

Residual tumor cells that drive disease relapse after chemotherapy do not have enhanced tumor initiating capacity. [PDF]

, 2012
Although chemotherapy is used to treat most advanced solid tumors, recurrent disease is still the major cause of cancer-related mortality. Cancer stem cells (CSCs) have been the focus of intense research in recent years because they provide a possible ...
de la Cruz, Cecile, Eastham-Anderson, Jeffrey, Hegde, Ganapati V, Jackson, Erica L, Sweet-Cordero, E Alejandro, Zheng, Yanyan   +5 more
core   +2 more sources

The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease

Stem cell research & therapeutics, 2019
The use and effectiveness of hematopoietic stem cell transplantation (HSCT) are limited by lethal complications, i.e., acute and chronic graft-versus-host disease (aGVHD and cGVHD, respectively), in which immune cells from the donor attack healthy ...
Lu Zhao, Shanquan Chen, Panxin Yang, H. Cao, Lanjuan Li   +4 more
semanticscholar   +1 more source

Physiological conditions influencing regenerative potential of stem cells [PDF]

, 2016
Stem cells are being used in the treatment of cardivovascular diseases. Here, we review the physiologic and pathologic conditions that impact the regenerative potential of stem cells in the treatment of cardiovascular diseases which include the influence
Avitabile, Daniele, De Falco, Elena, Gambini, Elisa, Spaltro, Gabriella   +3 more
core   +1 more source

Biodegradable chitin conduit tubulation combined with bone marrow mesenchymal stem cell transplantation for treatment of spinal cord injury by reducing glial scar and cavity formation

Neural Regeneration Research, 2015
We examined the restorative effect of modified biodegradable chitin conduits in combination with bone marrow mesenchymal stem cell transplantation after right spinal cord hemisection injury.
Feng Xue, Er-jun Wu, Pei-xun Zhang, Li-ya A, Yu-hui Kou, Xiao-feng Yin, Na Han   +6 more
doaj   +1 more source

Stem Cell Transplantation in the Treatment of Type 1 Diabetes Mellitus: From Insulin Replacement to Beta-Cell Replacement

Frontiers in Endocrinology, 2022
Type 1 diabetes mellitus (T1DM) is an autoimmune disease that attacks pancreatic β-cells, leading to the destruction of insulitis-related islet β-cells. Islet β-cell transplantation has been proven as a curative measure in T1DM.
Xin-Xing Wan, Dan-Yi Zhang, Md. Asaduzzaman Khan, Sheng-Yuan Zheng, Xi-Min Hu, Qi Zhang, Rong-Hua Yang, Kun Xiong, Kun Xiong, Kun Xiong   +9 more
doaj   +1 more source

New directions for the treatment of adrenal insufficiency [PDF]

, 2015
The following funding bodies supported this work: Biotechnology and Biological Sciences Research Council (BBSRC BB/L00267/1, to LG), Rosetrees Trust (to LG), Barts and The London Charity (417/2235, to LG), EU COFUND (PCOFUND-GA-2013-608765, to LG and GRB)
Allen, Allende, Badylak, Bancos, Berkes, Birke, Buaas, Chamoux, Chamoux, Clipsham, Cogger, Cox, Crawford, Drucker, Dubernard, El-Khairi, Else, Faulk, Fayard, Franksson, Freedman, Gallo-Payet, Gondo, Gondo, Grodstein, Guasti, Guasti, Hardy, Hardy, Hardy, Hardy, Hatano, Huang, Huang, Ibbertson, Jadhav, Kearns, Kim, King, Laufer, Ludwig, Luo, Mazilu, Parker, Sancho-Martinez, Schimmer, Schnabel, Sonoyama, Takahashi, Tanaka, Teebken, Thomas, Thomas, Thomas, Thomas, Thomas, Val, Val, Vierbuchen, Vouillarmet, Walczak, Walczak, Wei, Wilhelm, Wong, Yazawa, Yazawa, Yazawa, Yazawa, Zupekan   +69 more
core   +2 more sources

Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives

Gut and Liver, 2020
Mesenchymal stem cell transplantation is an emerging therapy for treating chronic liver diseases. The potential of this treatment has been evaluated in preclinical and clinical studies. Although the mechanisms of mesenchymal stem cell transplantation are
Seong Hee Kang, Moon Young Kim, Young Woo Eom, Soon Koo Baik   +3 more
doaj   +1 more source